Search | IOVS | ARVO Journals

View

Showing 1 – 18 of 18

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract April 2010

Comparative Analysis of Optical Coherence Tomography Imaging Through Gas Filled Eyes

S. P. Shah; V. Manjunath; G. Janzen; A. H. Rogers; C. Baumal; E. Reichel; J. S. Duker

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):343. doi:

ARVO Annual Meeting Abstract April 2009

Preoperative Morphological Characteristics of Epiretinal Membrane Evaluated by Optical Coherence Tomography Correlated With Postoperative Outcomes

J. J. Chieh; L. C. Castro; A. J. Witkin; F. I. Tolentino; C. R. Baumal; A. H. Rogers; E. Reichel; J. S. Duker

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):3292. doi:

ARVO Annual Meeting Abstract April 2009

Speckled Hyperpigmentation as a Positive Prognostic Indicator in Neovascular Age-Related Macular Degeneration

L. M. Smithen; J. S. Duker; E. Reichel; A. H. Rogers; C. R. Baumal; J. M. Seddon

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):236. doi:

ARVO Annual Meeting Abstract April 2009

Optical Coherence Tomography and Visual Acuity Results Correlated to the Initial Anatomic Response Following Intravitreal Injection of Ranibizumab in Wet Age-Related Macular Degeneration

L. C. Castro; C. Baumal; R. Chen; J. S. Duker; E. Reichel; A. H. Rogers

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2369. doi:

ARVO Annual Meeting Abstract April 2009

Initial Anatomic and Visual Results in Patients after Intravitreal Ranibizumab Injection for Neovascular Age-Related Macular Degeneration

R. W. Chen; J. S. Duker; E. Reichel; C. Baumal; A. H. Rogers

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2383. doi:

ARVO Annual Meeting Abstract April 2009

Surgical Outcomes of Vitrectomy for Vitreomacular Traction Syndrome

M. E. Patron; A. J. Witkin; L. C. Castro; E. Reichel; A. H. Rogers; C. R. Baumal; J. S. Duker

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):6051. doi:

ARVO Annual Meeting Abstract April 2009

Anatomic and Visual Outcomes of Vitrectomy for Lamellar Macular Holes

A. J. Witkin; L. C. Castro; E. Reichel; A. H. Rogers; C. R. Baumal; J. S. Duker

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):6052. doi:

ARVO Annual Meeting Abstract May 2008

Anatomic and Visual Outcomes of Non-Infectious Endophthalmitis After Intravitreal Triamcinolone

S. J. Yoon; D. Y. Rhee; J. L. Marx; G. R. Blaha; A. H. Rogers; C. R. Baumal; E. Reichel; J. S. Duker

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):964. doi:

ARVO Annual Meeting Abstract May 2008

Fellow Eye Response to Intravitreal Ranibizumab Injection in Neovascular Age-Related Macular Degeneration

L. M. Smithen; M. E. Patron; E. Reichel; A. H. Rogers; C. Baumal; J. M. Seddon; J. S. Duker

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):308. doi:

ARVO Annual Meeting Abstract May 2008

Initial Anatomic and Visual Outcomes After One Intravitreal Bevacizumab Injection for Neovascular Age-Related Macular Degeneration

C. C. Robinson; A. H. Rogers; E. Reichel; J. J. Chieh; T. Wiegand; C. Baumal; J. S. Duker

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):331. doi:

ARVO Annual Meeting Abstract May 2008

Complications of 23-Gauge Transconjunctival Vitrectomy Surgery

J. J. Chieh; A. H. Rogers; C. C. Robinson; T. W. Wiegand; C. Baumal; E. Reichel; J. S. Duker

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):2053. doi:

ARVO Annual Meeting Abstract May 2008

Ultrahigh Resolution Spectral Domain Optical Coherence Tomography Imaging Before and After Intravitreal Injection of Ranibizumab for Exudative Age-Related Macular Degeneration

A. J. Witkin; L. N. Vuong; V. J. Srinivasan; I. Gorczynska; C. R. Baumal; A. H. Rogers; J. G. Fujimoto; J. S. Duker

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):2231. doi:

ARVO Annual Meeting Abstract May 2008

Outcomes of 23-Gauge Vitrectomy Surgery for Primary Closure of Macular Holes

J. Chang; T. W. Wiegand; C. R. Baumal; A. H. Rogers; E. Reichel; J. S. Duker

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5969. doi:

ARVO Annual Meeting Abstract May 2007

Real-World Cost of Treating Neovascular Age-Related Macular Degeneration With Bevacizumab

L. M. Smithen; J. S. Duker; E. Reichel; C. R. Baumal; A. H. Rogers

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):2100. doi:

ARVO Annual Meeting Abstract May 2007

Staging of Central Serous Chorioretinopathy With High-speed Ultrahigh Resolution OCT

R. W. Chen; V. J. Srinivasan; J. S. Duker; E. Reichel; C. R. Baumal; A. H. Rogers; T. Hedges; M. Wojtkowski; J. S. Schuman; J. G. Fujimoto

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):2621. doi:

ARVO Annual Meeting Abstract May 2007

Intravitreal Injection of Bevacizumab (Avastin) for Choroidal Neovascularization Caused by Angioid Streaks

T. W. Wiegand; A. H. Rogers; P. Yates; E. Reichel; J. S. Duker

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):3396. doi:

ARVO Annual Meeting Abstract May 2007

Comparison of a Single Injection Versus Multiple Injections of Intravitreal Ranibizumab (Lucentis) for Choroidal Neovascularization Associated With Age-Related Macular Degeneration

D. Y. Rhee; S. J. Yoon; T. W. Wiegand; A. H. Rogers; C. R. Baumal; J. S. Duker; E. Reichel

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):4937. doi:

ARVO Annual Meeting Abstract May 2007

Enhanced Imaging of Macular Pathologies With the High Speed, Fourier Domain RTVue Optical Coherence Tomography Instrument

A. H. Rogers; R. W. Chen; J. S. Duker; C. R. Baumal; E. Reichel; I. Gorczynska; J. J. Liu; V. Srinivasan; J. S. Schuman; J. G. Fujimoto

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):5663. doi:

Advertisement